Single Patient Protocol for an NRG1 Fusion Positive Metastatic Pancreatic Cancer Patient Using Seribantumab
Latest Information Update: 18 Jan 2022
At a glance
- Drugs Seribantumab (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 22 Dec 2021 Status changed from not yet recruiting to completed.
- 11 Mar 2021 New trial record